Rebuilding biotech sector requires diversified training, say researchers

Canada's bio-economy will need an additional 65,000 workers by 2029, according to a report from BioTalent Canada.
Health Minister Jean-Yves Duclos announced on April 29 that biotechnology company Moderna will build a manufacturing facility in Quebec with the capacity to produce up to 100 million mRNA vaccine doses annually, as part of the federal government's biomanufacturing and life sciences strategy.
Canada’s preparedness to tackle future pandemics will hinge heavily on attracting more talent to the biotech sector, but also on diversifying training to allow researchers to handle different health emergencies, according to health researchers. “What we're short on right now are trained, skille...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.


Already a Subscriber?

Get Today’s Headlines Newsletter

Your quick scan of the news you need each weekday to be the smartest person in the room.


By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

MORE News

RELATED STORIES